Personal history of prostate cancer linked to melanoma risk

Personal history of prostate cancer linked to melanoma risk

(HealthDay)—History of prostate cancer (PCa) is associated with an increased risk of melanoma, according to a study published online Nov. 4 in the Journal of Clinical Oncology.

Wen-Qing Li, Ph.D., from the National Institutes of Health in Rockville, Md., and colleagues conducted a prospective study to examine the correlation between PCa and the risk of using data from 42,372 participants in the Health Professionals' Follow-Up Study (HPFS). Pathology reports were used to confirm biennially self-reported PCa and melanoma. The association was confirmed in 18,603 participants from the Physicians' Health Study (PHS).

The researchers identified 529 melanomas in the HPFS. The risk of melanoma was significantly increased with personal history of PCa (multivariate adjusted hazard ratio, 1.83; 95 percent confidence interval, 1.32 to 2.54), while the risk of non-melanoma skin cancer was marginally increased with PCa (hazard ratio, 1.08; 95 percent confidence interval, 0.995 to 1.16). There was a significant difference in the magnitude of the association between melanoma and non-melanoma skin cancer. The risk of melanoma was not associated with of other cancers. In the PHS, the association between PCa and risk of incident melanoma was confirmed (hazard ratio, 2.17).

"Our finding of PCa diagnosis as a risk predictor for melanoma holds general public health significance, which may inform clinical practice to address the queries and aid the care of patients with PCa," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Retinol supplementation may lower melanoma risk

Mar 05, 2012

(HealthDay) -- Retinol supplementation is associated with a lower risk of melanoma, according to research published online March 1 in the Journal of Investigative Dermatology.

Recommended for you

Taking the guesswork out of cancer therapy

36 minutes ago

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test ...

Brain tumour cells found circulating in blood

1 hour ago

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

International charge on new radiation treatment for cancer

2 hours ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

Computer model reveals cancer's energy source

3 hours ago

(Medical Xpress)—A computer model study reveals – for the first time – details of an energy-creating process vital and unique to cancer cells. The research holds promise for new interventions and for ...

User comments